© The Financial Times Ltd 2016
FT and 'Financial Times' are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
June 14, 2006 3:17 pm
All good things come in threes, or so it would seem. This week graduating MIT Sloan fellow David Lucchino and chemical engineering doctoral student Chris Loose added a third award to the prizes already won by their company SteriCoat, which is developing an antimicrobial coating for medical widgets and equipment.
The SteriCoat founders beat seven other groups from the US and the UK to win the “best pitch” award at the Cambridge Enterprise and MIT Entrepreneurship annual dinner. Earlier this year SteriCoat won the venture award at MIT’s $100k entrepreneurship competition and the Harvard Business School Biotechnology Business Plan Competition.
The process developed by SteriCoat uses vapour deposition technology to coat medical devices so that they inhibit the spread of infection following an operation or other medical procedure. The equipment coated could be anything from a catheter to a mechanical hip joint used in a hip replacement operation. In the US alone bloodstream infections associated with medical devices cause 70,000 deaths a year, according to SteriCoat.
The SteriCoat founders are now looking for angel funding so they can further establish the technology.
Teams from Imperial College, Manchester University and Oxford University joined teams from Cambridge University and MIT in this week’s presentations.
Copyright The Financial Times Limited 2016. You may share using our article tools.
Please don't cut articles from FT.com and redistribute by email or post to the web.